Showing results (141-150 of 330) with videos related to
Sort By:
Pageof 33
International Journal of Molecular Sciences|July 24, 2021
Antifungal Activity and Biosynthetic Potential of New Streptomyces sp. MW-W600-10 Strain Isolated from Coal Mine WaterPiotr Siupka, Frederik Teilfeldt Hansen, Aleksandra Schier, et al.The Oncologist|June 3, 2011
Outcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLCRaymond H Mak, Elizabeth Doran, Alona Muzikansky, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 30, 2016
First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain MetastasesMartin Schuler, Yi-Long Wu, Vera Hirsh, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 3, 2010
Phase I/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancerRebecca Suk Heist, Jerry Fain, Bernard Chinnasami, et al.Clinical Lung Cancer|March 24, 2012
Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancerGiorgio V Scagliotti, Silvia Novello, Joan H Schiller, et al.The Journal of Molecular Diagnostics : JMD|June 27, 2007
Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar featuresKarin E Finberg, Lecia V Sequist, Victoria A Joshi, et al.JAMA Network Open|March 31, 2022
Incidence of Radiation Therapy Among Patients Enrolled in a Multidisciplinary Pulmonary Nodule and Lung Cancer Screening ClinicMichael G Milligan, Inga T Lennes, Saif Hawari, et al.Cancer Discovery|May 3, 2015
Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR InhibitorZofia Piotrowska, Matthew J Niederst, Chris A Karlovich, et al.Nature Communications|June 11, 2016
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patientsJacob J Chabon, Andrew D Simmons, Alexander F Lovejoy, et al.Carbohydrate Research|March 9, 2023
Structure of the lipopolysaccharide O-antigen of endophytic Pseudomonas sp. strain L1Adam Choma, Zbigniew Kaczyński, Iwona Komaniecka, et al.Pageof 33